Searching for bacteria that protect against IBD
CMIT researchers are pinpointing bacterial species that trigger the development of special immune cells which may be protective against ulcerative colitis and other inflammatory disorders.
Cranking up the resolution
CMIT researchers and their collaborators have figured out how to circumvent those obstacles and enhance our understanding of the invisible communities in our guts.
CMIT participates in Crohn’s and Colitis Foundation community-based fundraiser
The Center for Microbiome Informatics and Therapeutics joined the New England Chapter of Crohn’s and Colitis Foundation for their annual spin4 crohn’s and colitis cures fundraiser
Manpower and manholes: Alm lab joins fight against Covid-19
When the Covid-19 pandemic was declared, both current and former members of the Alm lab jumped into action to help communities stay ahead of local case surges.
How industrialized life remodels the microbiome
A new study from an MIT-led team has revealed that these bacterial populations can remake themselves within the lifetime of their host, by passing genes back and forth.
Turning microbiome research into a force for health
A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.
Gut Microbiota Composition and Functional Changes in Inflammatory Bowel Disease and Irritable Bowel Syndrome
Authors unveil a large-scale metagenomic microbiome analysis from patients with both Inflammatory Bowel Disease and Irritable Bowel Syndrome.
Functional Heterogeneity in the Fermentation Capabilities of the Healthy Human Gut Microbiota
A new study by Gurry and fellow CMIT colleagues explores the relationship between fiber intake and microbial Short Chain Fatty Acid production
Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
In a recent study, researchers use single cell sequencing of intestinal tissue biopsies from diseased and healthy patients to create a cell atlas that lends novel insight into the cellular pathways that link implicated genes to UC pathophysiology.
Framework for Rational Donor Selection in Fecal Microbiota Transplant Clinical Trials
Fecal Microbiota Transplant (FMT) is gaining traction as a potentially effect treatment of the increasing number of diseases that have been linked to microbiome dysbiosis.